Viewing Study NCT03644069


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-02-25 @ 4:58 PM
Study NCT ID: NCT03644069
Status: UNKNOWN
Last Update Posted: 2019-03-19
First Post: 2018-05-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
Sponsor: ImmusanT, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module